Visiomed Group SA (0D13) Share Price & Analysis

1 Followers

0D13 Stock Chart & Stats

No data to display

Day’s Range: N/A
52-Week Range: N/A
Previous Close: N/A
Volume: N/A
Average Volume (3M): N/A
Market Cap: EUR 47.97M
Enterprise Value: EUR 67.47T
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 20.5
Beta: N/A
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Visiomed Group SA News

Visiomed publishes regulated half-year financial report

Visiomed Group SA ( ($FR:ALKLH) ) has provided an announcement. Visiomed Group SA has released its half-year financial and audit report for the period ended 30 June 2026, in line

1w ago7V91 0D13

Klea Holding Sees Revenue Rebound and Bets on Wellness and Pharma for Q4 Growth

Visiomed Group SA ( ($FR:ALKLH) ) has issued an update. Klea Holding reported unaudited third‑quarter 2026 revenue of €4.4 million, down 14% year‑on‑year on a reported basis, but highlighted a

3w ago7V91 0D13

Klea Holding Details Late-September Share Buybacks on Euronext Growth

An announcement from Visiomed Group SA ( ($FR:ALKLH) ) is now available. Klea Holding has disclosed recent share buyback transactions conducted on Euronext Growth Paris under the framework of the

4w ago7V91 0D13

Klea Holding Steps Up Share Buybacks Amid Middle East Expansion Strategy

Visiomed Group SA ( ($FR:ALKLH) ) has issued an update. Klea Holding has disclosed a series of share buyback transactions carried out on the Paris market between 21 and 24

1M ago7V91 0D13

Klea Holding Stays Profitable Amid Regional Turmoil and Bets on Middle East Healthcare Growth

Visiomed Group SA ( ($FR:ALKLH) ) has provided an announcement. Klea Holding, a Paris-listed healthcare group specialising in digital medical testing and pharmaceuticals across the Middle East and Africa, is

1M ago7V91 0D13

Klea Holding Boosts Capital Management With September Share Buybacks

The latest announcement is out from Visiomed Group SA ( ($FR:ALKLH) ). Klea Holding, a Paris-listed group active in the Middle East, specializes in digital medical analysis centers through Smart

1M ago7V91 0D13

Klea Holding Steps Up Share Buybacks as It Expands Middle East Healthcare Platform

The latest announcement is out from Visiomed Group SA ( ($FR:ALKLH) ). Klea Holding, a Paris-listed group targeting high-growth opportunities in Middle Eastern healthcare and pharmaceuticals, is building a platform

1M ago7V91 0D13

Klea Pharmaceuticals launches Gulf expansion with first UAE order and new leadership

Visiomed Group SA ( ($FR:ALKLH) ) has shared an update. Klea Pharmaceuticals, the drug-marketing subsidiary of Klea Holding, has confirmed its commercial launch in the Middle East and Africa, anchored

1M ago7V91 0D13

Klea Holding nears opening of self-financed digital medical centre in Riyadh

An update from Visiomed Group SA ( ($FR:ALKLH) ) is now available. Klea Holding said its Smart Health subsidiary has completed construction and fit-out of its first digital medical centre

1M ago7V91 0D13

Klea Holding Boosts Shareholder Value with Targeted Buyback Amid Middle East Expansion

Visiomed Group SA ( ($FR:ALKLH) ) has provided an update. Klea Holding, a Paris-based healthcare and pharmaceutical group listed on Euronext Growth, focuses on digitized medical analysis centers and licensed

2M ago7V91 0D13

0D13 FAQ

What is Visiomed Group SA’s market cap?

Visiomed Group SA’s market cap is €47.97M.

When is Visiomed Group SA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Visiomed Group SA’s earnings last quarter?

Visiomed Group SA released its earnings results on Mar 26, 2024. The company reported $0.005 earnings per share for the quarter.

Is Visiomed Group SA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Visiomed Group SA pay dividends?

Visiomed Group SA does not currently pay dividends.

What is Visiomed Group SA’s EPS estimate?

Visiomed Group SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Visiomed Group SA have?

Visiomed Group SA has 307,514,300 shares outstanding.

What happened to Visiomed Group SA’s price movement after its last earnings report?

Visiomed Group SA reported an EPS of $0.005 in its last earnings report. Following the earnings report the stock price went same ―.

Which hedge fund is a major shareholder of Visiomed Group SA?

Currently, no hedge funds are holding shares in GB:0D13

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description